Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Total Debt (2018 - 2026)

Orthofix Medical has reported Total Debt over the past 14 years, most recently at $221.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Total Debt rose 41.08% year-over-year to $221.3 million, compared with a TTM value of $221.3 million through Mar 2026, up 41.08%, and an annual FY2025 reading of $157.4 million, down 4.1% over the prior year.
  • Total Debt came in at $221.3 million for Q1 2026, up from $157.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $221.3 million in Q1 2026 to a low of $1.0 million in Q4 2022.
  • Median Total Debt over the past 5 years was $118.3 million (2024), compared with a mean of $116.4 million.
  • The sharpest move saw Total Debt crashed 94.19% in 2022, then surged 9335.7% in 2023.
  • Over 5 years, Total Debt stood at $1.0 million in 2022, then surged by 9335.7% to $94.4 million in 2023, then soared by 73.93% to $164.1 million in 2024, then fell by 4.1% to $157.4 million in 2025, then skyrocketed by 40.63% to $221.3 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Total Debt are $221.3 million (Q1 2026), $157.4 million (Q4 2025), and $157.2 million (Q3 2025).